Preoperative CT for Characterization of Aggressive Macrotrabecular-Massive Subtype and Vessels That Encapsulate Tumor Clusters Pattern in Hepatocellular Carcinoma
- PMID: 33973839
- DOI: 10.1148/radiol.2021203614
Preoperative CT for Characterization of Aggressive Macrotrabecular-Massive Subtype and Vessels That Encapsulate Tumor Clusters Pattern in Hepatocellular Carcinoma
Abstract
Background Macrotrabecular-massive (MTM) subtype and vessels encapsulating tumor clusters (VETC) pattern of hepatocellular carcinoma (HCC) are associated with unfavorable prognosis. Purpose To estimate the potential of preoperative CT in the prediction of MTM subtype and VETC pattern. Materials and Methods Patients who underwent surgical resection or liver transplant and preoperative CT for HCC between January 2015 and June 2018 were retrospectively included in the primary cohort. CT imaging features were evaluated by two radiologists. Predictors associated with the MTM subtype or VETC pattern were determined by using logistic regression analyses and the performance was tested in a validation cohort. Prognostic factors associated with early recurrence after surgical resection were identified by using Cox regression analyses. Results The primary cohort included 170 patients (median age, 55 years; interquartile range, 48-63 years; 152 men). Serum α-fetoprotein level higher than 100 ng/mL (odds ratio [OR], 4.3; 95% CI: 2.1, 9.2; P < .001), intratumor necrosis (OR, 5.2; 95% CI: 2.5, 11.0; P < .001), and intratumor hemorrhage (OR, 5.4; 95% CI: 1.3, 23.3; P = .02) were independent predictors for MTM subtype, whereas tumor size greater than 5 cm (OR, 3.8; 95% CI: 1.7, 8.1; P = .001) and intratumor necrosis (OR, 2.1; 95% CI: 1.0, 4.4; P = .045) were independent predictors for VETC pattern. These features were used for the construction of ANH and SN scores (where A is α-fetoprotein level, N is necrosis, H is hemorrhage, and S is size), respectively, which showed comparable prediction performance in the primary and validation cohorts. Preoperative high ANH and high SN phenotype (hazard ratio, 1.9; 95% CI: 1.2, 3.0; P = .01) was independently associated with early recurrence after surgical resection. Conclusion Preoperative CT features could be used for the characterization of macrotrabecular-massive subtype and vessels that encapsulate tumor clusters pattern and were of prognostic significance for early recurrence in patients with hepatocellular carcinoma. Online supplemental material is available for this article. See also the editorial by Yoon and Kim in this issue. Published under a CC BY 4.0 license.
Comment in
-
CT Characterization of Aggressive Macrotrabecular-Massive Hepatocellular Carcinoma: A Step Forward to Personalized Medicine.Radiology. 2021 Jul;300(1):230-232. doi: 10.1148/radiol.2021210379. Epub 2021 May 11. Radiology. 2021. PMID: 33973845 No abstract available.
Similar articles
-
Preoperative CT features for characterization of vessels that encapsulate tumor clusters in hepatocellular carcinoma.Eur J Radiol. 2024 Oct;179:111681. doi: 10.1016/j.ejrad.2024.111681. Epub 2024 Aug 12. Eur J Radiol. 2024. PMID: 39142009
-
Multiphase Liver MRI for Identifying the Macrotrabecular-Massive Subtype of Hepatocellular Carcinoma.Radiology. 2020 Jun;295(3):562-571. doi: 10.1148/radiol.2020192230. Epub 2020 Mar 31. Radiology. 2020. PMID: 32228294
-
A nomogram for preoperative prediction of vessels encapsulating tumor clusters (VETC) pattern and prognosis of hepatocellular carcinoma.Am J Surg. 2024 Aug;234:172-178. doi: 10.1016/j.amjsurg.2024.05.004. Epub 2024 May 5. Am J Surg. 2024. PMID: 38755026
-
MRI imaging features for predicting macrotrabecular-massive subtype hepatocellular carcinoma: a systematic review and meta-analysis.Eur Radiol. 2024 Oct;34(10):6896-6907. doi: 10.1007/s00330-024-10671-1. Epub 2024 Mar 20. Eur Radiol. 2024. PMID: 38507054
-
Macrotrabecular-Massive Hepatocellular Carcinoma: What Should We Know?J Hepatocell Carcinoma. 2022 May 5;9:379-387. doi: 10.2147/JHC.S364742. eCollection 2022. J Hepatocell Carcinoma. 2022. PMID: 35547829 Free PMC article. Review.
Cited by
-
A deep learning-based clinical-radiomics model predicting the treatment response of immune checkpoint inhibitors (ICIs)-based conversion therapy in potentially convertible hepatocelluar carcinoma patients: a tumor marker prognostic study.Int J Surg. 2025 May 1;111(5):3342-3355. doi: 10.1097/JS9.0000000000002322. Int J Surg. 2025. PMID: 40085751 Free PMC article.
-
Intravoxel Incoherent Motion Improves the Accuracy of Preoperative Prediction of Vessels Encapsulating Tumor Clusters in Hepatocellular Carcinoma.J Hepatocell Carcinoma. 2025 Jun 11;12:1177-1190. doi: 10.2147/JHC.S519223. eCollection 2025. J Hepatocell Carcinoma. 2025. PMID: 40524872 Free PMC article.
-
Gadoxetic Acid-Enhanced Magnetic Resonance Imaging Features Can Predict Immune-Excluded Phenotype of Hepatocellular Carcinoma.Liver Cancer. 2024 Nov 13;14(3):271-285. doi: 10.1159/000542099. eCollection 2025 Jun. Liver Cancer. 2024. PMID: 40547958 Free PMC article.
-
Prediction of Macrotrabecular-Massive Hepatocellular Carcinoma and Associated Prognosis Using Contrast-enhanced US and Clinical Features.Radiol Imaging Cancer. 2025 Jul;7(4):e240419. doi: 10.1148/rycan.240419. Radiol Imaging Cancer. 2025. PMID: 40607931 Free PMC article.
-
Evaluation and Prediction of Treatment Response for Hepatocellular Carcinoma.Magn Reson Med Sci. 2023 Apr 1;22(2):209-220. doi: 10.2463/mrms.rev.2022-0118. Epub 2023 Feb 16. Magn Reson Med Sci. 2023. PMID: 36792205 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical